Section numbers pertain to those in the full-text guideline. Significant relationship. Appendix 2. Reviewer Relationships With Industry and Other Entities (Relevant) 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update) Peer Reviewer Representation Employment Consultant Speaker s Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness John E. Brush Official Reviewer ACCF Board of Trustees Cardiology Consultants Healthcare Incentives Improvement Institute Board Member* United Healthcare Scientific Advisory Board None None None None None David P. Faxon Official Reviewer AHA Brigham and Women s Hospital Professor of Medicine Boston Scientific Sanofi-aventis None RIVA Medical None Circulation: Cardiovascular Interventions Editor None Robert A. Harrington Official Reviewer AHA Duke Clinical Research Institute Professor of Medicine; Duke University Medical Center Director Bristol-Myers Squibb Genentech* Gilead Sciences Merck Mitsubishi-Tanabe Momenta Pharmaceutical Pfizer* Regado Sanofi-aventis WebMD None None AstraZeneca Bristol-Myers Squibb GlaxoSmithKline Merck Portola Sanofi-aventis The Medicines Company None None Judith S. Hochman Official Reviewer ACCF/AHA Task Force on Practice Guidelines New York University School of Medicine Harold Snyder Family Professor of Cardiology; NYU-HHC Clinical and Translational Science Institute Co-Director; Leon Charney Division of Cardiology Clinical Chief; Cardiovascular Clinical Research Center Director Bristol-Myers Squibb Eli Lilly GlaxoSmithKline Sanofi-aventis None None Bayer Healthcare AG DSMB Johnson & Johnson DSMB Merck, TIMI 50 DSMB Schering-Plough, None None Rodney H. Zimmermann Official Reviewer ACCF Board of Governors Regina General Hospital Director of the Cardiac Catheterization Laboratory AstraZeneca Boehringer Ingelheim Hoffmann-La Roche AstraZeneca Boehringer Ingelheim Merck-Frost None Eli Lilly Schering-Plough None None Joseph C. Cleveland Organizational Reviewer STS University of Colorado Anschutz Medical Center Associate Professor of Surgery; Surgical Director, Cardiac Transplantation and MCS Baxter Biosurgery Sorin None None HeartWare Corporation Thoratec Corporation None None Joseph A. DeGregorio Organizational Reviewer SCAI Englewood Hospital Chief, Invasive Cardiology None None None None None None Deborah B. Diercks Organizational Reviewer ACEP UC Davis Medical Center None None None Beckman Coulter* AHRQ, QUADRICS Trial DSMB* Emergencies in Medicine* Society of Academic Emergency Medicine* Society of Chest Pain Centers and Providers* None Benjamin Hatten Organizational Reviewer ACEP Denver Health Medical Center None None None None None None Loren F. Hiratzka Organizational Reviewer STS Cardiac, Vascular and Thoracic Surgeons Medical Director, Cardiac Surgery None None None None None None Nancy M. Albert Content Reviewer ACCF/AHA Task Force on Practice Guidelines Cleveland Clinic, Kaufman Center for Heart Failure, Nursing Research, Innovation and CNS Senior Director Merck* None None None None None (Continued) Jneid et al 2012 UA/NSTEMI Focused Update 903 Appendix 2. 